Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 9/20 | 0.62 |
| ▸ | USP2 | O75604 | 8/20 | 0.62 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.62 |
| ▸ | TSHR | P16473 | 5/20 | 0.62 |
| ▸ | LMNA | P02545 | 2/20 | 0.62 |
| ▸ | MEN1 | O00255 | 2/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.62 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.60 |
| ▸ | RAB9A | P51151 | 1/20 | 0.60 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 4/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
| ▸ | PKM | P14618 | 2/20 | 0.53 |
| ▸ | XBP1 | P17861 | 1/20 | 0.51 |
| ▸ | GAA | P10253 | 2/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.49 |
| ▸ | CA1 | P00915 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28061822 | 0.79 | SMN1; SMN2 (0.73) | ALDH1A1TSHRLMNASMN1; SMN2RAB9A | |
| SCHEMBL29407800 | 0.79 | HTR6 (0.56) | MAPTUSP2ALDH1A1TSHRLMNA | |
| SCHEMBL6740206 | 0.78 | LMNA (0.70) | MAPTALDH1A1TSHRLMNAHTT | |
| SCHEMBL15658933 | 0.76 | MAPT (0.84) | MAPTUSP2ALDH1A1LMNAMEN1 | |
| SCHEMBL10016358 | 0.75 | SMN1; SMN2 (1.00) | USP2ALDH1A1TSHRLMNAMEN1 | |
| SCHEMBL1123739 | 0.74 | ALDH1A1 (0.58) | MAPTALDH1A1TSHRLMNASMN1; SMN2 | |
| SCHEMBL1123953 | 0.74 | ALDH1A1 (0.58) | MAPTALDH1A1TSHRLMNASMN1; SMN2 | |
| SCHEMBL1124078 | 0.73 | GAA (0.55) | MAPTALDH1A1TSHRLMNASMN1; SMN2 | |
| SCHEMBL12499681 | 0.73 | PIK3CA (0.73) | MAPTALDH1A1TSHRLMNASMN1; SMN2 | |
| SCHEMBL30192927 | 0.72 | SMN1; SMN2 (0.56) | MAPTALDH1A1TSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12091719-B2 | Compositions and methods for detecting viruses in a sample | WASHINGTON UNIVERSITY (US) | 2024-09-17 | — | — | US | claimed |
| US-12639706-B1 | Systems, methods, and program products for modifying the supply, depositing, holding, and/or distributing collateral as a stable value token in the form of digital assets | GEMINI IP, LLC (US) | 2026-05-26 | — | — | US | disclosed |
| US-12530681-B1 | System, method and program product for generating and utilizing stable value digital assets | GEMINI IP, LLC (US) | 2026-01-20 | — | — | US | disclosed |
| US-12493871-B1 | Systems, methods, and program products for non-custodial trading of digital assets on a digital asset exchange | GEMINI IP, LLC (US) | 2025-12-09 | — | — | US | disclosed |
| US-12354163-B1 | Systems, methods, and program products for non-custodial trading of digital assets on a digital asset exchange | GEMINI IP, LLC (US) | 2025-07-08 | — | — | US | disclosed |
| US-12277554-B1 | Systems, method, and program product for making payments using fiat-backed digital assets | GEMINI IP, LLC (US) | 2025-04-15 | — | — | US | disclosed |
| US-12271898-B1 | System, method and program product for modifying a supply of stable value digital asset tokens | GEMINI IP, LLC (US) | 2025-04-08 | — | — | US | disclosed |
| US-12265953-B1 | Systems, methods, and program products for non-custodial trading of digital assets on a digital asset exchange | GEMINI IP, LLC (US) | 2025-04-01 | — | — | US | disclosed |
| US-12141871-B1 | System, method and program product for generating and utilizing stable value digital assets | GEMINI IP, LLC (US) | 2024-11-12 | — | — | US | disclosed |
| US-12093942-B1 | Systems, methods, and program products for modifying the supply, depositing, holding, and/or distributing collateral as a stable value token in the form of digital assets | GEMINI IP, LLC (US) | 2024-09-17 | — | — | US | disclosed |
| US-11475442-B1 | System, method and program product for modifying a supply of stable value digital asset tokens | GEMINI IP, LLC (US) | 2022-10-18 | — | — | US | disclosed |
| US-11423482-B1 | Systems, methods, and program products for an application programming interface generating a blended digital math-based assets index | GEMINI IP, LLC (US) | 2022-08-23 | — | — | US | disclosed |
| EP-4043493-A1 | ANTI-VISTA ANTIBODIES AND FRAGMENTS | Janssen Pharmaceutica NV (BE) | 2022-08-17 | — | — | EP | disclosed |
| US-20220253842-A1 | SYSTEM, METHOD AND PROGRAM PRODUCT FOR MODIFYING A SUPPLY OF STABLE VALUE DIGITAL ASSET TOKENS | GEMINI IP, LLC | 2022-08-11 | — | — | US | disclosed |
| WO-2022121346-A1 | WALLET RETRIEVAL METHOD AND DEVICE, AND STORAGE MEDIUM | 杭州复杂美科技有限公司 | 2022-06-16 | — | — | WO | disclosed |
| US-11334883-B1 | Systems, methods, and program products for modifying the supply, depositing, holding and/or distributing collateral as a stable value token in the form of digital assets | GEMINI IP, LLC (US) | 2022-05-17 | — | — | US | disclosed |
| CN-113717623-B | Self-foaming multifunctional water-based moisture absorption coating and preparation method thereof | 安徽哈船新材料科技有限公司 | 2022-05-13 | — | — | CN | disclosed |
| US-11308487-B1 | System, method and program product for obtaining digital assets | GEMINI IP, LLC (US) | 2022-04-19 | — | — | US | disclosed |
| US-11282139-B1 | Systems, methods, and program products for verifying digital assets held in a custodial digital asset wallet | GEMINI IP, LLC (US) | 2022-03-22 | — | — | US | disclosed |
| EP-3712174-B1 | ANTI-VISTA ANTIBODIES AND FRAGMENTS | JANSSEN PHARMACEUTICA NV (BE) | 2022-03-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12530681-B1 | System, method and program product for generating and utilizing stable value digital assets | YEATS2, DSTN, YEATS4 | MAPT 2276/4885USP2 3067/4885ALDH1A1 4822/4885 |
| US-12639706-B1 | Systems, methods, and program products for modifying the supply, depositing, holding, and/or distributing collateral as a stable value token in the form of digital assets | AXIN2, CTPS2, USE1 | MAPT 2798/4885USP2 1467/4885ALDH1A1 4082/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.